Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
11/2012
11/07/2012CN101648145B Method for preparing asymmetric substituted aryl compound or terphenyl derivative by one-pot tandem reaction of functionalized imidazole salt and palladium salt
11/07/2012CN101448802B Acrylamide derivative as histone deacetylase inhibitors for cancer treatment
11/07/2012CN101287703B Pesticide bi-phenyl-amidine derivatives
11/06/2012US8304415 1, 2-disubstituted amido-anthraquinone derivatives, preparation method and application thereof
11/06/2012US8304409 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
11/01/2012WO2012145899A1 Ester compound, preparation method and application thereof
11/01/2012US20120277434 Methods for synthesizing quinolinone compounds
11/01/2012US20120277423 Protein crosslinking inhibitor and use of the same
11/01/2012US20120277250 Amidine-containing compounds useful as muscarinic receptor antagonists
10/2012
10/31/2012EP2516390A1 Method for preparing dithiocarbamates in particular from polyols of the glycerol type
10/31/2012EP2516387A2 New inhibitors of cyclophilins and uses thereof
10/31/2012CN102762586A Therapeutic peptides
10/31/2012CN102762545A Semiconducting polymers
10/31/2012CN102757380A Effective synthesizing method of piperidine and piperazine derivatives with alkyl chains
10/31/2012CN102755906A Application of amino aryloxy rare-earth metal-lithium amide used as catalyst
10/31/2012CN102093311B Method for preparing paramorpholinyl sulfoacylmethyl biphenyl
10/30/2012US8299259 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics
10/30/2012US8299249 Method for producing TETA by means of EDDN
10/30/2012US8299096 Method for treating pulmonary diseases using rho kinase inhibitor compounds
10/30/2012US8299094 Hepatitis C virus inhibitors
10/30/2012US8299075 Substituted thiomorpholine derivatives
10/30/2012CA2581730C New histone deacetylases inhibitors
10/30/2012CA2566297C Substituted cyclohexyl-1,4-diamine derivatives
10/26/2012WO2012143337A1 Novel modulators of cortical dopaminergic- and nmda-receptor-mediated glutamatergic neurotransmission
10/26/2012CA2832874A1 Novel modulators of cortical dopaminergic- and nmda-receptor-mediated glutamatergic neurotransmission
10/25/2012US20120271049 Bifunctional phenyl iso (thio) cyanates, processes and intermediates products for their preparation
10/25/2012US20120270901 Indene derivatives as pharmaceutical agents
10/25/2012US20120270877 IRE-1alpha INHIBITORS
10/25/2012US20120270836 Therapeutic approaches for treating alzheimer's disease
10/25/2012US20120269724 Compositions and methods for imaging tissues, organs and tumors
10/24/2012EP2514743A1 Immunosuppressant Compounds and Compositions
10/24/2012EP2513072A1 Pyrazine derivatives,process for manufacture and use thereof
10/24/2012EP2513057A1 Sphingosine kinase inhibitors
10/24/2012CN102753513A Process for preparing aryl- and heteroarylacetic acid derivatives
10/24/2012CN102746255A Compound having anti-tumor activity, and preparation method and application thereof
10/24/2012CN102746171A Preparation method and application research of water-soluble and oil-soluble novel phenoxy carboxylic acid ester derivative
10/23/2012US8293945 Method for producing an amine
10/23/2012US8293788 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them
10/23/2012US8293751 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
10/23/2012US8293075 Method for the continuous separation by distillation of mixtures that contain morphonline (MO), monoaminodiglycol (ADG), ammonia and water by means of distillation
10/23/2012CA2566526C Naphthaline derivatives useful as histamine-3-receptor ligands
10/18/2012WO2012141197A1 Organic electroluminescence element
10/18/2012WO2012113860A3 Phenalene-1-one derivatives, method for producing same and use thereof
10/18/2012WO2010130260A9 Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide
10/18/2012US20120264941 Method for preparing dithiocarbamates in particular from polyols of the glycerol type
10/18/2012US20120264765 Cyclohexane-1,3-Diones for Use in the Treatment of Amyotrophic Lateral Sclerosis
10/18/2012US20120264756 Phosphatidylcholine Transfer Protein Inhibitors
10/18/2012US20120263670 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
10/18/2012US20120260825 Polymeric dispersants
10/17/2012EP2511264A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
10/17/2012EP2509953A2 Methods of facilitating neural cell survival using gdnf family ligand (gfl) mimetics or ret signaling pathway activators
10/17/2012CN1948274B Verakanol derivative, preparation method and use thereof
10/17/2012CN102731437A Preparation method of 4-piperazine-3-trifluoromethylaniline hydrochloride
10/17/2012CN102731436A Preparation and refining method of repaglinide
10/17/2012CN102731435A Quaternary ammonium salt, electrolyte, solution and electrochemical device
10/17/2012CN102731354A Preparation and plant growth-regulating activity of water-oil soluble o-(4-chloro) benzylthio-benzoate derivatives
10/17/2012CN102731236A Alpha-amino cyclo nitrile compound preparation method
10/17/2012CN101891707B Method for preparing Quetiapine or pharmaceutically acceptable fumarate thereof
10/17/2012CN101693692B Hybrid ionic liquid hydrate, preparation process and application thereof
10/16/2012US8288397 Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of TRPV1
10/16/2012US8288368 inhibitors of the C5a induced chemotaxis; psoriasis, ulcerative cholitis, glomerular nephritis, acute respiratory insufficiency, idiopathic fibrosis, rheumatoid arthritis and in the prevention and the treatment of injury caused by ischemia and reperfusion
10/16/2012US8287849 Biodegradable poly(beta-amino esters) and uses thereof
10/16/2012CA2545296C Biphenyl derivatives useful as ligands that activate the rar receptors, process for preparing them and use thereof in human medicine and in cosmetics
10/11/2012WO2012137152A2 Method for preparing formamide compounds
10/11/2012WO2012099847A3 Compounds, monomers, and polymers containing a carbonate linkage
10/11/2012WO2012071102A3 Method for buffering a chemical or biological composition
10/11/2012US20120258971 Therapeutic agent for chronic pain
10/11/2012US20120258960 Novel multifunctional peptidase inhibitors, especially for medical use
10/11/2012US20120258886 Protected amine labels and use in detecting analytes
10/11/2012US20120255898 Semipermeable polymers and method for producing same
10/10/2012EP2507229A1 Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
10/10/2012EP2507210A1 Cyclohexane derivatives as inhibitors of acetyl-coa carboxylase (acc)
10/10/2012CN102718722A Preparation and application research of water-soluble and oil-soluble novel aryloxy phenoxy carboxylate derivatives
10/10/2012CN101821245B New compounds
10/10/2012CN101560175B Thiourea derivatives and preparation method and use thereof
10/10/2012CN101450934B Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/10/2012CN101341125B New phenanthridine derivatives as bradykinin antagonists
10/09/2012US8282888 Method and apparatus for the use of [11C] carbon monoxide in labeling synthesis by photo-initiated carbonylation
10/09/2012CA2550598C Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method and their use in therapy
10/04/2012WO2012130299A1 Peptidase inhibitors
10/04/2012WO2010023687A3 Preparation of ranolazine, its salts and intermediates thereof
10/04/2012US20120252790 Amino-Derivatives As Novel Inhibitors Of Histone Deacetylase
10/04/2012US20120252789 Inhibitors of sphingosine kinase
10/04/2012US20120252776 C4 Monomethyl Triterpenoid Derivatives and Methods of Use Thereof
10/04/2012US20120251492 Triterpene derivative and agent for preventing or treating chronic hepatitis c
10/03/2012CN102712587A Novel ethane diamine hepcidin antagonists
10/03/2012CN102702401A Synthesis method of cationic polyacrylamide with ionic degree of 65-78%
10/03/2012CN102702138A Repaglinide compound and novel production method thereof
10/03/2012CN102702137A Synthesis of chiral ionic liquid based on (R)-thiazolidine-2-thione-4-carboxylic acid
10/03/2012CN102702052A Novel diamine-containing farnesyl thiosalicylic acid derivative and preparation method and medicinal application thereof
10/02/2012US8278489 Method for producing an amine
10/02/2012US8278482 Antimicrobial N-chlorinated compositions
10/02/2012US8278329 Antagonizing N-type calcium channels; use as analgesic, neurodegenerative diseases, brain injury, bronchial asthma, unstable angina and irritable colitis, drug withdrawal symptoms; t-butyl 2-[4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-piperidinyl]-2-oxoethylcarbamate for example
10/02/2012US8278308 Diketopiperazine salts for drug delivery and related methods
10/02/2012CA2649784C Mono-nitration of aromatic compounds by addition of solutions or suspensions of nitrate salts to acids
10/02/2012CA2504207C New amide compounds having mch-antagonistic activity and medicaments comprising these compounds
09/2012
09/27/2012WO2012047907A9 Synthesis of c5-substituted tetracyclines, uses thereof, and intermediates thereto
09/27/2012US20120245348 New Cyclopentadienyl, Indenyl or Fluorenyl Substituted Phosphine Compounds and their Use in Catalytic Reactions
09/27/2012US20120245141 Activators of human pyruvate kinase
09/27/2012US20120245138 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl arylsulfonamides
1 ... 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 ... 341